Should I buy or sell ReWalk Robotics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RWLK shares. View RWLK analyst ratings or view top-rated stocks .

What is ReWalk Robotics' stock price target for 2024?

1 analysts have issued 12-month price targets for ReWalk Robotics' shares. Their RWLK share price targets range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next twelve months. View analysts price targets for RWLK or view top-rated stocks among Wall Street analysts .

How were ReWalk Robotics' earnings last quarter?

ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) EPS for the quarter, hitting analysts' consensus estimates of ($0.06). The medical device company had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%. During the same quarter in the previous year, the firm posted ($0.18) EPS.

What other stocks do shareholders of ReWalk Robotics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI) , Prospect Capital (PSEC) , Calumet Specialty Products Partners (CLMT) , Two Harbors Investment (TWO) , BlackRock Capital Investment (BKCC) , NovoCure (NVCR) , Viper Energy (VNOM) , Summit Midstream Partners (SMLP) , Washington Prime Group (WPG) and Roper Technologies (ROP) .

NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

Free RWLK Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.64
▼
$1.25
52-Week Range: N/A

Volume: 303,600 shs
Average Volume: 541,468 shs
Market Capitalization: $63.04 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Short Interest Social Media

Get ReWalk Robotics alerts:

ReWalk Robotics MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: ∞ Upside
$3.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.38) to ($0.37) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.62 out of 5 stars

Medical Sector

860th out of 918 stocks

Medical Devices Industry

3rd out of 3 stocks

3.5

Analyst's Opinion

Consensus Rating
ReWalk Robotics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
ReWalk Robotics has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for RWLK.

0.0

Dividend Strength

Dividend Yield
ReWalk Robotics does not currently pay a dividend.
Dividend Growth
ReWalk Robotics does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RWLK.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for ReWalk Robotics this week, compared to 1 article on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ReWalk Robotics insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.10% of the stock of ReWalk Robotics is held by insiders.
Percentage Held by Institutions
Only 3.58% of the stock of ReWalk Robotics is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for ReWalk Robotics are expected to grow in the coming year, from ($0.38) to ($0.37) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ReWalk Robotics is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ReWalk Robotics is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

About ReWalk Robotics Stock (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Ad Stansberry Research

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

RWLK Stock News Headlines

April 18, 2024 | finance.yahoo.com

ReWalk Robotics Ltd. (LFWD)

March 22, 2024 | globenewswire.com

VA STAND Act introduced in the United States Senate

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

March 13, 2024 | globenewswire.com

Lifeward Announces Reverse Share Split

March 8, 2024 | globenewswire.com

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

March 1, 2024 | globenewswire.com

Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered

February 27, 2024 | globenewswire.com

Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results

February 20, 2024 | globenewswire.com

Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024

April 19, 2024 | Stansberry Research (Ad)

Strange new buyer driving up gold

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

February 15, 2024 | uk.investing.com

Rewalk Robotics Ltd (LFWD)

February 15, 2024 | uk.investing.com

Rewalk Robotics Ltd (RWLK)

February 13, 2024 | cnn.com

ReWalk Robotics Ltd.

February 6, 2024 | finance.yahoo.com

7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market

January 31, 2024 | finanznachrichten.de

ReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

January 31, 2024 | msn.com

Rewalk Robotics Rebrands as Lifeward, Announces New Ticker

January 15, 2024 | finance.yahoo.com

ReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past week

January 12, 2024 | finance.yahoo.com

ReWalk Robotics Expands Direct Sales Coverage to Canada

January 11, 2024 | finance.yahoo.com

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

January 5, 2024 | finanznachrichten.de

ReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by Medicare

January 5, 2024 | finance.yahoo.com

First ReWalk Personal Exoskeleton Claim Paid by Medicare

January 4, 2024 | finance.yahoo.com

ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities

November 30, 2023 | finance.yahoo.com

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

November 28, 2023 | finanznachrichten.de

ReWalk Robotics Ltd.: ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

November 28, 2023 | finance.yahoo.com

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

November 14, 2023 | finanznachrichten.de

ReWalk Robotics Ltd.: ReWalk Robotics Reports Third Quarter 2023 Financial Results

November 14, 2023 | finance.yahoo.com

ReWalk Robotics Reports Third Quarter 2023 Financial Results

November 13, 2023 | benzinga.com

Preview: ReWalk Robotics's Earnings

See More Headlines

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/11/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: NASDAQ:RWLK
CUSIP: N/A
CIK: 1607962
Web: www.rewalk.com
Phone: (724) 959-0123
Fax: N/A
Employees: 56
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $3.00
High Stock Price Target: $3.00
Low Stock Price Target: $3.00
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.37)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-19,570,000.00
Net Margins: -238.35%
Pretax Margin: -233.51%
Return on Equity: -29.00%
Return on Assets: -25.27%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.47
Quick Ratio: 2.99

Sales & Book Value

Annual Sales: $5.51 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.10 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 60,030,000
Free Float: 58,764,000
Market Cap: $63.04 million
Optionable: Optionable
Beta: 2.30

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Lawrence J. Jasinski BS (Age 67)
MBA, CEO & Director
Comp: $654.03k
Mr. Michael A. Lawless (Age 56)
Chief Financial Officer
Comp: $110.24k
Ms. Miri Pariente (Age 47)
Vice President of Operations, Regulatory & Quality
Comp: $335.1k
Ms. Jeannine Lynch (Age 59)
Vice President of Market Access & Strategy
Comp: $425.98k
Ms. Kathleen O'Donnell
Vice President of Marketing & New Business Development
Mr. Charles Remsberg
Chief Sales Officer
Ms. Judy Kula
Vice President of Customer Service, Human Resources & Business Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RWLK Stock Analysis - Frequently Asked Questions

Should I buy or sell ReWalk Robotics stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RWLK shares.
View RWLK analyst ratings or view top-rated stocks.
What is ReWalk Robotics' stock price target for 2024?: 1 analysts have issued 12-month price targets for ReWalk Robotics' shares. Their RWLK share price targets range from $3.00 to $3.00. On average, they predict the company's share price to reach $3.00 in the next twelve months.
View analysts price targets for RWLK or view top-rated stocks among Wall Street analysts.
How were ReWalk Robotics' earnings last quarter?: ReWalk Robotics Ltd. (NASDAQ:RWLK) issued its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($0.06) EPS for the quarter, hitting analysts' consensus estimates of ($0.06). The medical device company had revenue of $1.97 million for the quarter, compared to analyst estimates of $1.60 million. ReWalk Robotics had a negative net margin of 238.35% and a negative trailing twelve-month return on equity of 29.00%. During the same quarter in the previous year, the firm posted ($0.18) EPS.
What other stocks do shareholders of ReWalk Robotics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP).

This page (NASDAQ:RWLK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ReWalk Robotics (RWLK) Stock Price, News & Analysis

ReWalk Robotics MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Company Ownership

Earnings and Valuation

About ReWalk Robotics Stock (NASDAQ:RWLK)

RWLK Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

RWLK Stock Analysis - Frequently Asked Questions

Overall MarketRank^™